sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> peptide therapeutics market

report

Peptide Therapeutics Market, by Route of Administration (Oral, Parental, Mucosal, Transdermal), Applications (Cardiovascular, Cancer, Metabolic Disorders, Central Nervous System, Gastrointestinal Disorders, Infection, Hematological Disorders, Respiratory Disorders, Dermatology, Endocrinology), Drug Types (Branded Drugs, Generic Drugs) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC184 November 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the peptide therapeutics market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the peptide therapeutics market. The scope of this report covers the peptide therapeutics market by its major segments, which include the routes of administration, applications, drug types, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The increasing prevalence of chronic disorders, the emergence of the most prominent biotechnology and pharmaceutical companies, and advancements in the synthetic peptides are the major factors fuelling the growth of the peptide therapeutic market during the forecast period.
  • Others factors such as favorable government regulations for the startups and the increasing FDI in the developing nations and the rise in the disposable income will further boost the growth of the peptide therapeutics market.
  • High efficacy of the peptides, strong pipelines, advancements in technology, and patent expirations are some of the other factors fuelling the growth of the market for peptide therapeutics.
  • Various other factors, such as increasing oral bioavailability of the peptide drugs, regulatory conditions, and the cost effectiveness will further drive the peptide therapeutics market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s peptide therapeutics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the peptide therapeutics market by the following segments:

  • Peptide Therapeutics Market, by Route Of Administration
    • Oral
    • Parental
    • Mucosal
    • Transdermal
  • Peptide Therapeutics Market, by Applications
    • Cardiovascular Diseases
    • Cancer
    • Metabolic Disorders
    • Central Nervous System Diseases
    • Gastrointestinal Diseases
    • Infectious Diseases
    • Hematologic Diseases
    • Respiratory Diseases
    • Dermatologic Diseases
    • Endocrine Diseases
  • Peptide Therapeutics Market, by Drug Types
    • Branded Drugs
    • Generic Drugs

KEY MARKET PLAYERS

Key players in the peptide therapeutics market include:

  • Eli Lilly and Company
  • AstraZeneca plc
  • CordenPharma International GmbH
  • Bachem Holding AG
  • Teva Pharmaceutical Industries Ltd.
  • Ipsen S.A.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • PolyPeptide Group

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Peptide Therapeutics Market

TRENDING RELATED REPORT

Pen Needles Market, by Needle Length, (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Types (Safety Pen Needles, Standard Pen Needles), Therapies (Insulin, Growth Hormone, Glucagon-Like Peptide-1 Therapy) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Pricing Analysis
    3. Regulatory Analysis
    4. Reimbursement Landscape
  5. PEPTIDE THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION
    1. Segment Share
    2. By Route of Administration
      1. Oral
      2. Parental
      3. Mucosal
      4. Transdermal
  6. PEPTIDE THERAPEUTICS MARKET, BY APPLICATIONS
    1. Segment Share
    2. By Applications
      1. Cardiovascular Diseases
      2. Cancer
      3. Metabolic Disorders
      4. Central Nervous System Diseases
      5. Gastrointestinal Diseases
      6. Infectious Diseases
      7. Hematologic Diseases
      8. Respiratory Diseases
      9. Dermatologic Diseases
      10. Endocrine Diseases
  7. PEPTIDE THERAPEUTICS MARKET, BY DRUG TYPES
    1. Segment Share
    2. By Drug Types
      1. Branded Drugs
      2. Generic Drugs
  8. PEPTIDE THERAPEUTICS MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Application
      3. By Route of Administration
      4. By  Drug Type
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Application
      3. By Route of Administration
      4. By  Drug Type
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Application
      3. By Route of Administration
      4. By  Drug Type
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Application
      3. By Route of Administration
      4. By  Drug Type
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovator Companies
  10. KEY MARKET PLAYERS
    1. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. AstraZeneca
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Corden Pharma International GmbH
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Bachem
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Teva Pharmaceutical Industries Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Ipsen
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Merck & Co., Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Novo Nordisk A/S
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. PolyPeptide Group
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us